Novel pulmonary vascular imaging signs in COVID-19 : pathophysiology, significance and management
© 2021 The Authors. Published by the British Institute of Radiology..
A growing body of evidence points to the frequent involvement of pulmonary microvessels in COVID-19 which was recognized first on CT, and subsequently demonstrated by clinical and pathological studies. Microvasculopathy occurring chiefly from endothelial and pericyte damage with resultant disruption of immune, thrombotic and renin-angiotensin-aldosterone balance leads to a constellation of clinical and biochemical derangements. Exploration of potential therapies directed at normalizing the vascular health can prove a major boon in the treatment of COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
BJR open - 2(2021), 1 vom: 20., Seite 20210001 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Parry, Arshed Hussain [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 13.08.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1259/bjro.20210001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329258273 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329258273 | ||
003 | DE-627 | ||
005 | 20231225204727.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1259/bjro.20210001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329258273 | ||
035 | |a (NLM)34381939 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Parry, Arshed Hussain |e verfasserin |4 aut | |
245 | 1 | 0 | |a Novel pulmonary vascular imaging signs in COVID-19 |b pathophysiology, significance and management |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 13.08.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2021 The Authors. Published by the British Institute of Radiology. | ||
520 | |a A growing body of evidence points to the frequent involvement of pulmonary microvessels in COVID-19 which was recognized first on CT, and subsequently demonstrated by clinical and pathological studies. Microvasculopathy occurring chiefly from endothelial and pericyte damage with resultant disruption of immune, thrombotic and renin-angiotensin-aldosterone balance leads to a constellation of clinical and biochemical derangements. Exploration of potential therapies directed at normalizing the vascular health can prove a major boon in the treatment of COVID-19 | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Wani, Abdul Haseeb |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BJR open |d 2019 |g 2(2021), 1 vom: 20., Seite 20210001 |w (DE-627)NLM314376909 |x 2513-9878 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2021 |g number:1 |g day:20 |g pages:20210001 |
856 | 4 | 0 | |u http://dx.doi.org/10.1259/bjro.20210001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2 |j 2021 |e 1 |b 20 |h 20210001 |